Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Autistic spectrum disorders

Rehnstrom, K., Ylisaukko-Oja, T., Vanhala, R., von Wendt, L., Peltonen, L., and Hovatta, I. (2008). No association between common variants in glyoxalase 1 and autistic spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 1478,124 127. [Pg.148]

Hotvath, K., Stefanatos, G., Sokolski, K.N., Wachtel, R., Nabors, L., and Tildon, J.T. (1998) Improved social and language skills after secretin administtation in patients with autistic spectrum disorders. / Assoc Acad Minor Phys 9 9—15. [Pg.577]

Buitelaar, J.K. and Willemsen-Swinkels, S.H.N. (2000) Medication treatment in subjects with autistic spectrum disorders. Eur Child Adolesc Psychiatry 9 85—97. [Pg.754]

The Importance of Catatonia and Stereotypies in Autistic Spectrum Disorders... [Pg.454]

Catatonia in Autistic Spectrum Disorders A Medical Treatment Algorithm... [Pg.454]

Halsey NA, Hyman SLConference Writing Panel. Measles-mumps-rubella vaccine and autistic spectrum disorder report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook. Illinois, June 12-13, 2000Pediatrics 2001 107(5) E84. [Pg.713]

Canitano R, Scandurra V (2008) Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 4 723-730 Carlson NR (2001) Physiology of behavior. Allyn and Bacon, Boston, MA Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ (2004) Treating autistic spectrum disorders in children utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 19 165-169... [Pg.392]

Coplan J, Senders MC, Mulberg AE, Belchic JK, Wray J, Jawad AF, Gallagher PR, Mitchell R, Gerdes M, Levy SE. Children with autistic spectrum disorders. II parents are unable to distinguish secretin from placebo under double-blind conditions. Arch Dis Child 2003 88(8) 737-9. [Pg.3109]

Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder a critical review of published original data. Pediatrics 2004 114(3) 793-804. [Pg.779]

Wing L, Potter D. The epidemiology of autistic spectrum disorders Is the prevalence rising Ment Retard Dev Disabil Res Rev 2002 8(3) 151 61. [Pg.346]

California Department of Developmental Services. Autistic spectrum disorders, changes in the California caseload, an update 1999-2002. Department of Developmental Services, 1600 9th St., Rm. 240, Sacramento, CA, May 2003. [Pg.348]

Valicenti-McDermott, M, McVicar, K, Rapin, I, WeshUl, BK, Cohen, H, and Shinnar, S (2006) Frequency of gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry 61 492 97. [Pg.13]

Bolton PF, Dennis NR, Browne CE, Thomas NS, Veltman MW, Thompson RJ, Jacobs P (2001) The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders. Am J Med Genet 105 675-685. [Pg.123]

Chez MG, Aimonovitch M, Buchanan T, Meazek S, Tremb RJ (2004) Treating autistic spectrum disorders in children utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol 19 165-169. [Pg.154]

Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, RivieUo JJ, Robinson RG, Neuman RJ, Deuel RMK (2006) Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59 354-363. [Pg.154]

Canitano R (2005) Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders. Brain Dev 27 228-232. [Pg.262]

Garstang 1, WaUis M (2006) Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 32 585-589. [Pg.263]

Luby J, Mrakotsky C, Stalets MM, Belden A, Heffelfinger A, Williams M, Spitznagel E (2006) Risperidone in preschool children with autistic spectrum disorders an investigation of safety and efficacy. J Child Adolesc Psychopharmacol 16 575-587. [Pg.264]

Wiggs L, Stores G (2004) Sleep patterns and sleep disorders in children with autistic spectrum disorders insights using parent report and actigraphy. Dev Med Child Neurol 46 372-380. [Pg.266]

Although a wide range of drugs are used to ameliorate symptoms of autistic behavior, currently there is no effective treatment. We discuss novel treatments such as use of cholinesterase inhibitors and nicotinic receptor antagonists as intervention therapies for treatment of the cognitive and non-cognitive changes in the autistic spectrum disorders. [Pg.274]

See other pages where Autistic spectrum disorders is mentioned: [Pg.437]    [Pg.88]    [Pg.123]    [Pg.123]    [Pg.124]    [Pg.132]    [Pg.205]    [Pg.548]    [Pg.684]    [Pg.714]    [Pg.2215]    [Pg.2222]    [Pg.147]    [Pg.152]    [Pg.152]    [Pg.168]    [Pg.217]    [Pg.276]    [Pg.201]    [Pg.374]   
See also in sourсe #XX -- [ Pg.437 ]

See also in sourсe #XX -- [ Pg.2 , Pg.3 , Pg.4 , Pg.5 , Pg.6 , Pg.7 , Pg.8 , Pg.13 , Pg.14 , Pg.15 , Pg.19 , Pg.21 , Pg.22 , Pg.69 , Pg.72 , Pg.73 , Pg.74 , Pg.75 , Pg.78 , Pg.147 , Pg.152 , Pg.167 , Pg.168 , Pg.175 , Pg.176 , Pg.177 , Pg.181 , Pg.201 , Pg.202 , Pg.208 , Pg.217 , Pg.218 , Pg.219 , Pg.224 , Pg.229 , Pg.234 , Pg.235 , Pg.236 , Pg.237 , Pg.238 , Pg.239 , Pg.240 , Pg.246 , Pg.247 , Pg.248 , Pg.249 , Pg.250 , Pg.251 , Pg.252 ]



SEARCH



Autistic spectrum disorders and

© 2024 chempedia.info